Dr Reddy'S Laboratories Ltd header image

Dr Reddy'S Laboratories Ltd

RDY

Equity

ISIN null / Valor 1221723

New York Stock Exchange, Inc (2026-11-03)
USD 14.30+1.20%

Dr Reddy'S Laboratories Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Dr. Reddy's Laboratories Ltd is a global pharmaceutical company headquartered in India, engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products. The company operates through various business segments including Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars, and over-the-counter (OTC) pharmaceutical products. Dr. Reddy's has a strong focus on meeting patient needs in several therapeutic areas such as gastroenterology, cardiovascular, diabetology, oncology, pain management, and dermatology. In addition to its existing product portfolio, the company is actively developing a pipeline of novel small molecules in immuno-oncology and working on differentiated products that aim to improve upon existing therapeutic agents. Furthermore, Dr. Reddy's is investing in emerging fields like digital therapeutics, cell, and gene therapies, indicating its commitment to innovation and addressing unmet medical needs.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

6.64%1Y
11.2%3Y
11.8%5Y

Performance

27.9%1Y
135%3Y
105%5Y

Volatility

Market cap

11912 M

Market cap (USD)

Daily traded volume (Shares)

2,656,058

Daily traded volume (Shares)

1 day high/low

15.85 / 15.68

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 45.30
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.36%USD 4.31
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.08%USD 14.29
Evotec SE
Evotec SE Evotec SE Valor: 505433
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.85%EUR 2.86
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.37%USD 4.30
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.84%USD 1.29
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%USD 25.70
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.03%USD 36.39
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%USD 3.50
Addus HomeCare Corp
Addus HomeCare Corp Addus HomeCare Corp Valor: 10385048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%USD 126.55